Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Truss CBD USA was a Colorado-based joint venture formed by Molson Coors Beverage Company and HEXO to develop and commercialize non-alcoholic, hemp-derived CBD beverages in the United States. The company launched the Veryvell brand, including sparkling CBD waters and beverage drops, positioned around functional wellness occasions such as focus, mind and body balance, and unwind/relaxation. Its products combined hemp-derived cannabidiol with adaptogens and were initially launched in Colorado before expanding e-commerce availability to multiple U.S. states. Truss CBD USA operated as a standalone entity with its own management and go-to-market strategy, but Molson Coors and HEXO later agreed to unwind the U.S. joint venture effective December 31, 2022. The business was more accurately a cannabinoid wellness beverage venture than a traditional biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Truss CBD USA.